Wynn Capital LLC Invests $994,000 in The Cigna Group (NYSE:CI)

Wynn Capital LLC purchased a new position in shares of The Cigna Group (NYSE:CIFree Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,319 shares of the health services provider’s stock, valued at approximately $994,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Avestar Capital LLC boosted its holdings in The Cigna Group by 0.8% in the third quarter. Avestar Capital LLC now owns 4,585 shares of the health services provider’s stock worth $1,312,000 after purchasing an additional 35 shares during the period. Eads & Heald Wealth Management lifted its stake in The Cigna Group by 1.7% in the third quarter. Eads & Heald Wealth Management now owns 2,123 shares of the health services provider’s stock valued at $607,000 after buying an additional 35 shares during the last quarter. Relyea Zuckerberg Hanson LLC lifted its stake in The Cigna Group by 3.2% in the fourth quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider’s stock valued at $333,000 after buying an additional 35 shares during the last quarter. Strategic Blueprint LLC lifted its stake in The Cigna Group by 4.8% in the third quarter. Strategic Blueprint LLC now owns 784 shares of the health services provider’s stock valued at $224,000 after buying an additional 36 shares during the last quarter. Finally, E&G Advisors LP lifted its stake in The Cigna Group by 1.8% in the third quarter. E&G Advisors LP now owns 2,137 shares of the health services provider’s stock valued at $611,000 after buying an additional 37 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of recent research reports. Oppenheimer reiterated an “outperform” rating and issued a $360.00 target price on shares of The Cigna Group in a research note on Wednesday, January 17th. Mizuho lifted their price objective on shares of The Cigna Group from $360.00 to $370.00 and gave the company a “buy” rating in a research note on Monday, February 5th. Cantor Fitzgerald restated an “overweight” rating and set a $384.00 price objective on shares of The Cigna Group in a research note on Wednesday, April 10th. Wells Fargo & Company lifted their price objective on shares of The Cigna Group from $334.00 to $348.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 6th. Finally, StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Thursday, March 14th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $362.14.

Check Out Our Latest Stock Report on The Cigna Group

The Cigna Group Trading Down 0.1 %

CI traded down $0.38 during trading on Wednesday, reaching $352.27. The company had a trading volume of 1,120,784 shares, compared to its average volume of 1,588,393. The firm’s 50-day simple moving average is $349.03 and its 200 day simple moving average is $316.84. The company has a market cap of $102.99 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 1.08 and a beta of 0.56. The Cigna Group has a 12-month low of $240.50 and a 12-month high of $365.71. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.67 and a current ratio of 0.67.

The Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, topping analysts’ consensus estimates of $6.54 by $0.25. The firm had revenue of $51.15 billion for the quarter, compared to analysts’ expectations of $48.91 billion. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The Cigna Group’s revenue was up 11.8% on a year-over-year basis. During the same quarter last year, the business posted $4.96 EPS. Equities research analysts anticipate that The Cigna Group will post 28.36 earnings per share for the current year.

The Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Investors of record on Tuesday, June 4th will be paid a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a yield of 1.59%. The Cigna Group’s dividend payout ratio is currently 32.20%.

Insider Buying and Selling

In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares of the company’s stock, valued at approximately $694,668.96. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares of the company’s stock, valued at approximately $694,668.96. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Eric P. Palmer sold 1,017 shares of The Cigna Group stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $335.26, for a total value of $340,959.42. Following the transaction, the insider now directly owns 45,564 shares in the company, valued at approximately $15,275,786.64. The disclosure for this sale can be found here. In the last quarter, insiders have sold 114,144 shares of company stock valued at $39,296,330. 0.70% of the stock is owned by corporate insiders.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.